Common Stock, Shares, Issued of Can-Fite BioPharma Ltd. from Q4 2018 to Q2 2025

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Can-Fite BioPharma Ltd. quarterly Common Stock, Shares, Issued history and change rate from Q4 2018 to Q2 2025.
  • Can-Fite BioPharma Ltd. Common Stock, Shares, Issued for the quarter ending 30 Jun 2025 was 3.97B shares, a 137% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Common Stock, Shares, Issued (shares)

Period Value YoY Chg Change % Date Report Filed
Q2 2025 3.97B +2.3B +137% 30 Jun 2025 6-K 28 Aug 2025
Q4 2024 2.98B +1.62B +119% 31 Dec 2024 6-K 28 Aug 2025
Q2 2024 1.67B +447M +36.5% 30 Jun 2024 6-K 29 Aug 2024
Q4 2023 1.36B +544M +66.7% 31 Dec 2023 20-F 14 Apr 2025
Q2 2023 1.22B +409M +50.1% 30 Jun 2023 6-K 31 Aug 2023
Q4 2022 816M 0 0% 31 Dec 2022 20-F 28 Mar 2024
Q2 2022 816M +300M +58.2% 30 Jun 2022 6-K 25 Aug 2022
Q4 2021 816M +352M +75.9% 31 Dec 2021 20-F 30 Mar 2023
Q2 2021 516M +104M +25.4% 30 Jun 2021 6-K 26 Aug 2021
Q4 2020 464M +343M +284% 31 Dec 2020 20-F 24 Mar 2022
Q2 2020 411M 30 Jun 2020 6-K 27 Aug 2020
Q4 2019 121M +80.3M +199% 31 Dec 2019 20-F 25 Mar 2021
Q4 2018 40.4M 31 Dec 2018 6-K 01 Jun 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.